Low molecular weight heparin half life is prolonged in haemodialysed patients
- 1 July 1986
- journal article
- Published by Elsevier in Thrombosis Research
- Vol. 43 (1), 1-5
- https://doi.org/10.1016/0049-3848(86)90039-3
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Disappearance of circulating anti-Xa activity after intravenous injection of standard heparin and of a low molecular weight heparin (CY 216) in normal and nephrectomized rabbitsThrombosis Research, 1985
- Binding and endocytosis of heparin by human endothelial cells in cultureBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1985
- Low haematocrit and prolonged bleeding time in uraemic patients: effect of red cell transfusionsBritish Journal of Haematology, 1985
- The relationship between the hemorrhagic and antithrombotic properties of low molecular weight heparin in rabbitsBlood, 1982
- Heparin Pharmacokinetics: Increased Requirements in Pulmonary EmbolismBritish Journal of Haematology, 1978
- Heparin half‐life in normal and impaired renal functionClinical Pharmacology & Therapeutics, 1974